Becton Dickinson and Co had 20 patents in artificial intelligence during Q4 2023. The patents filed by Becton Dickinson and Co in Q4 2023 include systems and methods for automatic determination of medical devices for vascular access, automated inventory management of healthcare items, recommending medical devices for vascular access using ultrasound, predicting National Drug Codes using artificial intelligence, and applying machine learning to extract clinically significant data from messages for resource allocation in clinical workflows. GlobalData’s report on Becton Dickinson and Co gives a 360-degreee view of the company including its patenting strategy. Buy the report here.

Smarter leaders trust GlobalData

Report-cover

Data Insights Becton Dickinson and Co - Company Profile

Buy the Report

Data Insights

The gold standard of business intelligence.

Find out more

Becton Dickinson and Co grant share with artificial intelligence as a theme is 20% in Q4 2023. Grant share is based on the ratio of number of grants to total number of patents.

Recent Patents

Application: Systems and methods for automatic determination of a medical device for vascular access (Patent ID: US20230420105A1)

The patent filed by Becton Dickinson and Co. describes a system and method for automatically determining the appropriate medical devices for vascular access before directly assessing a patient. The system includes a console with processors and memory that can analyze various data inputs, operating parameters, and historical data to recommend suitable medical devices using logic, algorithms, machine learning, or artificial intelligence. The system can display these recommendations on an integrated screen and can also incorporate clinician training confirmation and messaging for proper use.

Additionally, the system can automatically pull in data inputs such as patient condition parameters, orders from electronic medical systems, and clinician input to make recommendations based on procedure type, clinical rules, clinician experience, medical device inventory, and more. The system can also factor in infusion therapy parameters, imaging parameters, prior difficulty in access, patient condition, and clinician experience to provide accurate recommendations. Furthermore, the system can include additional features like ultrasound imaging, tip-location sensors, and infusion pumps to enhance the process of determining the appropriate medical devices for vascular access.

To know more about GlobalData’s detailed insights on Becton Dickinson and Co, buy the report here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.